Citations 1
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy
Gopal, Ajay K. , Flowers, Christopher R. , Martin, Peter , Ansell, Stephen M. , Abella-Dominicis, Esteban, Koh, Brian D. , Ye, Wei , Salles, Gilles , Friedberg, Jonathan W. , Kahl, Brad S. , Barr, Paul M. , Salles, Gilles A , Gopal, Ajay
Blood | March 22, 2017 | Volume: 129 | Issue: 22 | Pages: 3037-3039
